Atul (500027) Q3 25/26 earnings summary

Executive summary

• Achieved 11% year-over-year revenue growth for the nine months ended December 31, 2025, with improved profitability across key segments.

• Standalone and consolidated unaudited financial results for Q3 and nine months ended December 31, 2025, were reviewed and approved by the Board and auditors without modification.

• Enhanced product mix and higher sales in Pharmaceuticals and Crop Protection sub-segments contributed to better margins.

• Recognized with multiple industry awards for innovation and supply chain excellence.

• Results prepared in accordance with Ind AS and SEBI regulations, with segment information disclosed in consolidated results.

Financial highlights

• Nine-month consolidated revenue reached ₹4,603.47 crore, up 11% year-over-year.

• EBITDA for the period was ₹863 crore, a 15% increase year-over-year; EBITDA margin improved to 19%.

• Profit after tax (PAT) rose 30% year-over-year to ₹478.27 crore; EPS increased 31% to ₹159.

• Q3 FY26 consolidated revenue was ₹1,573.62 crore; net profit after tax was ₹163.54 crore.

• Basic and diluted EPS for Q3: Standalone ₹41.15; Consolidated ₹54.60.

Outlook and guidance

• Power supply from a new 13.2 MW hybrid renewable energy agreement is scheduled to commence by March 2027.

• Continued focus on capacity expansion, new product commercialization, and sustainability initiatives.

• The company is monitoring the impact of new labour codes and will adjust estimates as rules are finalized.